Merck, Glenmark Can Introduce 'Justifications' In Zetia Trial
Merck and Glenmark will be able to tell a jury the reasons they believe their decision to delay generic competition for the cholesterol medication Zetia was actually good for consumers after...To view the full article, register now.
Already a subscriber? Click here to view full article